Sujing

Project Cases

Gege Honglin Biopharmaceutical (Jiangsu) Co., Ltd.

+
  • 歌戈红林 (1).jpg
  • 歌戈红林 (2).jpg
  • 歌戈红林 (3).jpg
  • 歌戈红林 (4).jpg
  • 歌戈红林 (5).jpg
  • 歌戈红林 (6).jpg
  • 歌戈红林 (7).jpg
  • Description
  • Project name: Purification and electromechanical installation project of cGMP solid preparation workshop of Zhenjiang New Factory
    Owner name: Gege Honglin Biopharmaceutical (Jiangsu) Co., Ltd.
    Project industry sector: Health-Biomedicine
    Project scale: 13773m², purification area of about 10000m²
    Purification level: Overall Class 1000, local Class 100 ultra-clean (Grande C)

    The cGMP solid dosage workshop project of the Zhenjiang new plant of Gogo Honglin Biopharmaceutical (Jiangsu) Co., Ltd. is jointly invested by Gogo Pharmaceuticals of the United States and Beijing Honglin Biopharmaceuticals with a total investment of US$120 million. The project construction content includes modern GMP pharmaceutical production plants, office buildings, laboratory testing centers and other buildings. It will use a new generation of imported advanced automated production equipment to realize intelligent R&D and production, and promote high-quality development of the industry.

项目名称:镇江新工厂cGMP固体制剂车间净化机电安装工程

项目所属行业板块:大健康—生物医药

项目实施周期:2023年 4月~2024 年 6月

项目规模:13773平方,净化面积约10000平方

净化等级:整体千级,局部百级超净(Grande C)